Home Newsfeeds Edward Jones Upgrades Activision Blizzard to Buy

Edward Jones Upgrades Activision Blizzard to Buy

Edward Jones analyst Logan Purk upgrades Activision Blizzard (NASDAQ:ATVI) from Hold to Buy.

byBenzinga Newsdesk

December 6, 2022

1 minute read

Edward Jones analyst Logan Purk upgrades Activision Blizzard (NASDAQ:ATVI) from Hold to Buy.

Architect Behind iPhone’s Screen Tech, Touch ID Rumored To Depart Apple

By Ananya Gairola

December 7, 3:38 AM

Steve Hotelling, Apple's vice president, who has been under hardware boss Johny Srouji, has made significant contributions to the company's technological advances.

AAPL

FTX Founder In Deep Legal Trouble, Demands Insurers Pay Up To Cover Fees

By Murtuza Merchant

March 16, 10:12 AM

FTX (CRYPTO: FTT) founder Sam Bankman-Fried filed a motion Wednesday requesting that Relm Insurance and Beazley Insurance prioritize reimbursing his

$FTT

Analyst Ratings

Analyst Scoreboard: 4 Ratings For Winnebago Industries

By Benzinga Insights

December 21, 12:01 PM

In the preceding three months, 4 analysts have released ratings for Winnebago Industries (NYSE:WGO), presenting a wide array…

WGO

Citius Pharmaceuticals, Inc. Receives Regulatory Guidance From The FDA Regarding The Planned Resubmission Of The BLA For LYMPHIR; Resubmission To FDA Planned For Early 2024

By Benzinga Newsdesk

September 8, 8:02 AM

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ:CTXR) is pleased to announce the Company has received additional guidance from the U.S. Food and Drug Administration (FDA) regarding the planned

CTXR

Edward Jones Upgrades Activision Blizzard to Buy

Related Posts

Architect Behind iPhone’s Screen Tech, Touch ID Rumored To Depart Apple

FTX Founder In Deep Legal Trouble, Demands Insurers Pay Up To Cover Fees

Analyst Scoreboard: 4 Ratings For Winnebago Industries

Citius Pharmaceuticals, Inc. Receives Regulatory Guidance From The FDA Regarding The Planned Resubmission Of The BLA For LYMPHIR; Resubmission To FDA Planned For Early 2024